Given the higher prevalence of genomic and transcriptomic alteration of several PHFs, such as PYGO2, ZMYND8, ASXL1, and CHD3, it is necessary to further characterize their structures, roles, and the molecular mechanisms of the PHD domain that are implicated in breast cancer initiation and progression. The gene discussed is PYGO2; the disease is breast carcinoma.